ISTA PHARMACEUTICAL (NASDAQ:ISTA)
4.19
+0.10 (2.44%)
| ISTA PHARMACEUTICAL (NASDAQ:ISTA) Delayed : |
| Previous Close |
$4.09 |
|
52 Week High |
$6.83 |
|
| Open |
$4.06 |
|
52 Week Low |
$0.40 |
| Day High |
$4.20 |
|
P/E |
N/A |
| Day Low |
$3.83 |
|
EPS |
$-1.78 |
| Volume |
193,348 |
|
|
|
| More ISTA Info:
Chart
SEC Filings
Profile
Historical
Options
|
View All ReportsStreetInsider.com Reports on ISTA
-
Nov 3, 2009 06:03 PM
After-Hours Movers 11/03: QLTY, PACR, BGCP, TESO Higher; STEC, TRLG, CLRT, CRL, MYGN Lower
-
Nov 3, 2009 04:38 PM
ISTA Pharmaceuticals (ISTA) Tops Q3 EPS by 3c; Guides In-line for FY Revenues
-
Nov 2, 2009 01:40 PM
Trading Radar for 11/03: UBS (UBS), Yamana Gold (AUY), Archer-Daniels (ADM), Royal Caribbean (RCL), Marathon (MRO) Report
-
Sep 9, 2009 09:34 AM
Morning Movers 9/9: ENCO, VVUS, CLZR, WAVX, HITK, ISTA Higher; HNAB, ENWV, UWBK, AVAV, PBY Lower
-
Sep 9, 2009 07:19 AM
ISTA (ISTA) Announces FDA Approval for Bepreve, Results Fro T-Pred Studies
View All Reports
StreetInsider Reports on ISTA by Category
Comments on recent ISTA articles
Comments on ISTA
No comments are currently available.
on Nov 13, 2009
at 03:55 PM ANDREW OLIVER SATCHELL EXCELLENT
Article: Trading Radar for 11/03: UBS (UBS), Yamana Gold (AUY), Archer-Daniels (ADM), Royal Caribbean (RCL), Marathon (MRO) Report
on Aug 5, 2009
at 10:00 PM ISTA This company has wonderful products and will grow revenues painstakingly slowly. The REAL worth of ISTA is its share value to a corporate buyer. My cost basis is < $1 ... I'm holding for what I see as an inevitable buyout. I'm in the business/industry. Their products are unique and their competitors in BIG pharma can't catch up with comparable products for less than they can pay for ISTA. Bart
Article: ISTA Pharma (ISTA) Reports Q2 Results; Raises FY09 Sales Guidance